| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: Analysis from the treatment approaches in renal cancer global evaluation trial (TARGET)
|
Choueiri, Toni K.
|
|
2013
|
31 |
8 |
p. 1788-1793
6 p.
|
artikel
|
| 2 |
Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers
|
Niegisch, Günter
|
|
2013
|
31 |
8 |
p. 1770-1779
10 p.
|
artikel
|
| 3 |
Changing epidemiologic features of testicular germ cell cancer in Germany: Corroboration at population level
|
Stang, Andreas
|
|
2013
|
31 |
8 |
p. 1839-1840
2 p.
|
artikel
|
| 4 |
Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: A retrospective analysis☆
|
Pal, Sumanta K.
|
|
2013
|
31 |
8 |
p. 1826-1831
6 p.
|
artikel
|
| 5 |
Cognitive problems in patients on androgen deprivation therapy: A qualitative pilot study
|
Wu, Lisa M.
|
|
2013
|
31 |
8 |
p. 1533-1538
6 p.
|
artikel
|
| 6 |
Commentary on “Abiraterone in metastatic prostate cancer without previous chemotherapy.” Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, Fizazi K, Mainwaring P, Piulats JM, Ng S, Carles J, Mulders PF, Basch E, Small EJ, Saad F, Schrijvers D, Van Poppel H, Mukherjee SD, Suttmann H, Gerritsen WR, Flaig TW, George DJ, Yu EY, Efstathiou E, Pantuck A, Winquist E, Higano CS, Taplin ME, Park Y, Kheoh T, Griffin T, Scher HI, Rathkopf DE; COU-AA-302 Investigators, Genitourinary Medical Oncology Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA.
|
Trump, Donald L.
|
|
2013
|
31 |
8 |
p. 1846-
1 p.
|
artikel
|
| 7 |
Commentary on “Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): A randomised, open-label, phase 3 trial.” Gravis G, Fizazi K, Joly F, Oudard S, Priou F, Esterni B, Latorzeff I, Delva R, Krakowski I, Laguerre B, Rolland F, Théodore C, Deplanque G, Ferrero JM, Pouessel D, Mourey L, Beuzeboc P, Zanetta S, Habibian M, Berdah JF, Dauba J, Baciuchka M, Platini C, Linassier C, Labourey JL, Machiels JP, El Kouri C, Ravaud A, Suc E, Eymard JC, Hasbini A, Bousquet G, Soulie M, Medical Oncology and Biostatistics, Institut Paoli-Calmettes, Marseille, France.
|
Trump, Donald L.
|
|
2013
|
31 |
8 |
p. 1845-
1 p.
|
artikel
|
| 8 |
Commentary on “Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.” Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, Vogelzang NJ, Small EJ, Harzstark AL, Gordon MS, Vaishampayan UN, Haas NB, Spira AI, Lara PN Jr, Lin CC, Srinivas S, Sella A, SchoffskiSchöffski P, Scheffold C, Weitzman AL, Hussain M, University of Michigan, Ann Arbor, MI
|
Trump, Donald L.
|
|
2013
|
31 |
8 |
p. 1848-
1 p.
|
artikel
|
| 9 |
Commentary on “Intermittent versus continuous androgen deprivation in prostate cancer.” Hussain M, Tangen CM, Berry DL, Higano CS, Crawford ED, Liu G, Wilding G, Prescott S, Kanaga Sundaram S, Small EJ, Dawson NA, Donnelly BJ, Venner PM, Vaishampayan UN, Schellhammer PF, Quinn DI, Raghavan D, Ely B, Moinpour CM, Vogelzang NJ, Thompson IM Jr., University of Michigan, Division of Hematology/Oncology, 1500 E Medical Center Dr., 7314 CC, Ann Arbor, MI.
|
Trump, Donald L.
|
|
2013
|
31 |
8 |
p. 1847-
1 p.
|
artikel
|
| 10 |
Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: Is transrectal ultrasound suitable to determine which patients should undergo active surveillance?
|
Weiss, Brian E.
|
|
2013
|
31 |
8 |
p. 1436-1440
5 p.
|
artikel
|
| 11 |
Contents
|
|
|
2013
|
31 |
8 |
p. vii-xii
nvt p.
|
artikel
|
| 12 |
Contrasted effects of the multitarget TKi vandetanib on docetaxel-sensitive and docetaxel-resistant prostate cancer cell lines
|
Guérin, Olivier
|
|
2013
|
31 |
8 |
p. 1567-1575
9 p.
|
artikel
|
| 13 |
C-reactive protein: A biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy
|
Obata, Jun
|
|
2013
|
31 |
8 |
p. 1725-1730
6 p.
|
artikel
|
| 14 |
Defining prostate cancer risk before prostate biopsy
|
Pal, Raj P.
|
|
2013
|
31 |
8 |
p. 1408-1418
11 p.
|
artikel
|
| 15 |
DNMT1: An emerging target in the treatment of invasive urinary bladder cancer
|
Dhawan, Deepika
|
|
2013
|
31 |
8 |
p. 1761-1769
9 p.
|
artikel
|
| 16 |
Editorial Board
|
|
|
2013
|
31 |
8 |
p. vi-
1 p.
|
artikel
|
| 17 |
Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: Implications for prior therapy in clinical trials
|
Pond, Gregory R.
|
|
2013
|
31 |
8 |
p. 1457-1463
7 p.
|
artikel
|
| 18 |
Fas expression in nephrectomized, non-cancerous specimens predicts post-nephrectomy chronic kidney disease progression in patients with renal and upper urinary tract malignancies
|
Sejima, Takehiro
|
|
2013
|
31 |
8 |
p. 1812-1819
8 p.
|
artikel
|
| 19 |
Genetic analysis of the principal genes related to prostate cancer: A review
|
Alvarez-Cubero, Maria Jesus
|
|
2013
|
31 |
8 |
p. 1419-1429
11 p.
|
artikel
|
| 20 |
Health-related quality of life for men with prostate cancer—an evaluation of outcomes 12–24 months after treatment
|
Brassell, Stephen A.
|
|
2013
|
31 |
8 |
p. 1504-1510
7 p.
|
artikel
|
| 21 |
How reliable are “reputable sources” for medical information on the Internet? The case of hormonal therapy to treat prostate cancer
|
Ogah, Imhokhai
|
|
2013
|
31 |
8 |
p. 1546-1552
7 p.
|
artikel
|
| 22 |
Indications for and anatomical extent of pelvic lymph node dissection for prostate cancer: Practice patterns of uro-oncologists in North America
|
Touijer, Karim A.
|
|
2013
|
31 |
8 |
p. 1517-1521.e2
150584 p.
|
artikel
|
| 23 |
Information for Authors
|
|
|
2013
|
31 |
8 |
p. II-
1 p.
|
artikel
|
| 24 |
Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guérin
|
Dinney, Colin P.N.
|
|
2013
|
31 |
8 |
p. 1635-1642
8 p.
|
artikel
|
| 25 |
Inverted papilloma of the bladder: A review and an analysis of the recent literature of 365 patients
|
Picozzi, Stefano
|
|
2013
|
31 |
8 |
p. 1584-1590
7 p.
|
artikel
|
| 26 |
LASP-1, a Novel Urinary Marker for Detection of Bladder Cancer
|
Ardelt, Peter
|
|
2013
|
31 |
8 |
p. 1591-1598
8 p.
|
artikel
|
| 27 |
Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo
|
Jinesh G., Goodwin
|
|
2013
|
31 |
8 |
p. 1676-1682
7 p.
|
artikel
|
| 28 |
Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study
|
Shih, Cheryl
|
|
2013
|
31 |
8 |
p. 1689-1695
7 p.
|
artikel
|
| 29 |
Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5–4 ng/ml
|
Qi, Peter
|
|
2013
|
31 |
8 |
p. 1527-1532
6 p.
|
artikel
|
| 30 |
Long-term outcomes of radiotherapy for stage II testicular seminoma–the Mayo Clinic experience
|
Hallemeier, Christopher L.
|
|
2013
|
31 |
8 |
p. 1832-1838
7 p.
|
artikel
|
| 31 |
Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy
|
Rink, Michael
|
|
2013
|
31 |
8 |
p. 1716-1724
9 p.
|
artikel
|
| 32 |
Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma
|
Rojas, Claudia P.
|
|
2013
|
31 |
8 |
p. 1696-1700
5 p.
|
artikel
|
| 33 |
Low ERCC1 expression is associated with prolonged survival in patients with bladder cancer receiving platinum-based neoadjuvant chemotherapy
|
Ozcan, Muhammet Fuat
|
|
2013
|
31 |
8 |
p. 1709-1715
7 p.
|
artikel
|
| 34 |
Masthead
|
|
|
2013
|
31 |
8 |
p. v-
1 p.
|
artikel
|
| 35 |
Modified orthotopic spiral ileal bladder substitution: Surgical technique and long-term results
|
Wang, Wei-Gao
|
|
2013
|
31 |
8 |
p. 1599-1605
7 p.
|
artikel
|
| 36 |
Morbidity and costs of salvage vs. primary radical prostatectomy in older men
|
Prasad, Sandip M.
|
|
2013
|
31 |
8 |
p. 1477-1482
6 p.
|
artikel
|
| 37 |
Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma
|
Kim, Kwang Hyun
|
|
2013
|
31 |
8 |
p. 1643-1649
7 p.
|
artikel
|
| 38 |
Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: A retrospective analysis from the University of Southern California
|
Fairey, Adrian S.
|
|
2013
|
31 |
8 |
p. 1737-1743
7 p.
|
artikel
|
| 39 |
Nodal staging score: A tool for survival prediction of node-negative bladder cancer
|
Ku, Ja Hyeon
|
|
2013
|
31 |
8 |
p. 1731-1736
6 p.
|
artikel
|
| 40 |
Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: With mean follow-up of 3.5 years
|
Mmeje, Chinedu O.
|
|
2013
|
31 |
8 |
p. 1621-1627
7 p.
|
artikel
|
| 41 |
Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era
|
Dorin, Ryan P.
|
|
2013
|
31 |
8 |
p. 1441-1447
7 p.
|
artikel
|
| 42 |
Paraneoplastic symptoms: Cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma
|
Ding, Guan-xiong
|
|
2013
|
31 |
8 |
p. 1820-1825
6 p.
|
artikel
|
| 43 |
PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience
|
Ramos, Christian G.
|
|
2013
|
31 |
8 |
p. 1522-1526
5 p.
|
artikel
|
| 44 |
Plasma microRNA profiles for bladder cancer detection
|
Adam, Liana
|
|
2013
|
31 |
8 |
p. 1701-1708
8 p.
|
artikel
|
| 45 |
Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma
|
Jou, Yeong-Chin
|
|
2013
|
31 |
8 |
p. 1806-1811
6 p.
|
artikel
|
| 46 |
Preoperative estimated glomerular filtration rate predicts overall mortality in patients undergoing radical prostatectomy
|
Tollefson, Matthew K.
|
|
2013
|
31 |
8 |
p. 1483-1488
6 p.
|
artikel
|
| 47 |
Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification
|
Abdollah, Firas
|
|
2013
|
31 |
8 |
p. 1497-1503
7 p.
|
artikel
|
| 48 |
Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy
|
Li, Tao
|
|
2013
|
31 |
8 |
p. 1539-1545
7 p.
|
artikel
|
| 49 |
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma
|
Milojevic, Bogomir
|
|
2013
|
31 |
8 |
p. 1615-1620
6 p.
|
artikel
|
| 50 |
Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy
|
Miyake, Hideaki
|
|
2013
|
31 |
8 |
p. 1511-1516
6 p.
|
artikel
|
| 51 |
Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: Results from the UroScreen-Study
|
Banek, Severine
|
|
2013
|
31 |
8 |
p. 1656-1662
7 p.
|
artikel
|
| 52 |
Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells
|
Ye, Lin
|
|
2013
|
31 |
8 |
p. 1576-1583
8 p.
|
artikel
|
| 53 |
8q24 and 17q Prostate cancer susceptibility loci in a multiethnic Asian cohort
|
Chan, Jason Yongsheng
|
|
2013
|
31 |
8 |
p. 1553-1560
8 p.
|
artikel
|
| 54 |
RETRACTED: Modified U-shaped ileal neobladder after radical cystectomy: Assessment of functional outcomes and complications in Chinese patients
|
Zhong, Shan
|
|
2013
|
31 |
8 |
p. 1683-1688
6 p.
|
artikel
|
| 55 |
Risk factors for biochemical recurrence following radical perineal prostatectomy in a large contemporary series: A detailed assessment of margin extent and location
|
Sammon, Jesse D.
|
|
2013
|
31 |
8 |
p. 1470-1476
7 p.
|
artikel
|
| 56 |
Segmental ureterectomy for upper tract urothelial carcinoma: Two procedures with different indications
|
Xylinas, Evanguelos
|
|
2013
|
31 |
8 |
p. 1841-1843
3 p.
|
artikel
|
| 57 |
Simultaneous progression of oxidative stress, angiogenesis, and cell proliferation in prostate carcinoma
|
Pande, Deepti
|
|
2013
|
31 |
8 |
p. 1561-1566
6 p.
|
artikel
|
| 58 |
Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development
|
Wu, Kaijie
|
|
2013
|
31 |
8 |
p. 1751-1760
10 p.
|
artikel
|
| 59 |
Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence
|
Zhao, Juping
|
|
2013
|
31 |
8 |
p. 1800-1805
6 p.
|
artikel
|
| 60 |
Survey Section Editorial Board
|
|
|
2013
|
31 |
8 |
p. 1844-
1 p.
|
artikel
|
| 61 |
The characteristics of bladder cancer after radiotherapy for prostate cancer
|
Abern, Michael R.
|
|
2013
|
31 |
8 |
p. 1628-1634
7 p.
|
artikel
|
| 62 |
The effect of race and gender on the surgical management of the small renal mass
|
Kates, Max
|
|
2013
|
31 |
8 |
p. 1794-1799
6 p.
|
artikel
|
| 63 |
The effect of tumor location on prognosis in patients with primary ureteral urothelial carcinoma
|
Li, Wei-Ming
|
|
2013
|
31 |
8 |
p. 1670-1675
6 p.
|
artikel
|
| 64 |
The follicle-stimulating hormone receptor: A novel target in genitourinary malignancies
|
Gartrell, Benjamin A.
|
|
2013
|
31 |
8 |
p. 1403-1407
5 p.
|
artikel
|
| 65 |
The lymphatic system in clinically localized urothelial carcinoma of the bladder: Morphologic characteristics and predictive value
|
Bolenz, Christian
|
|
2013
|
31 |
8 |
p. 1606-1614
9 p.
|
artikel
|
| 66 |
The prognostic value of transrectal ultrasound guided biopsy in patients over 70 years old with a prostate specific Antigen (PSA) level ≤15 ng/ml and normal digital rectal examination: A 10-year prospective follow-up study of 427 consecutive patients
|
Mohamed, Zakir K.
|
|
2013
|
31 |
8 |
p. 1489-1496
8 p.
|
artikel
|
| 67 |
The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community setting
|
Liang, Yuanyuan
|
|
2013
|
31 |
8 |
p. 1464-1469
6 p.
|
artikel
|
| 68 |
The Role of Hypoxia-Inducible Factor-1α and -2α in Androgen Insensitive Prostate Cancer Cells
|
Jeong, Chang Wook
|
|
2013
|
31 |
8 |
p. 1448-1456
9 p.
|
artikel
|
| 69 |
3.0 T multiparametric prostate MRI using pelvic phased-array coil: Utility for tumor detection prior to biopsy
|
Rosenkrantz, Andrew B.
|
|
2013
|
31 |
8 |
p. 1430-1435
6 p.
|
artikel
|
| 70 |
Transplantation techniques for the resection of renal cell carcinoma with tumor thrombus: A technical description and review
|
Gorin, Michael A.
|
|
2013
|
31 |
8 |
p. 1780-1787
8 p.
|
artikel
|
| 71 |
Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009
|
Smaldone, Marc C.
|
|
2013
|
31 |
8 |
p. 1663-1669
7 p.
|
artikel
|
| 72 |
Urine Cell-Free DNA integrity as a marker for early bladder cancer diagnosis: Preliminary data
|
Casadio, Valentina
|
|
2013
|
31 |
8 |
p. 1744-1750
7 p.
|
artikel
|
| 73 |
Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: Impact of mandatory central pathology review at a large referral hospital
|
Shah, Rajal B.
|
|
2013
|
31 |
8 |
p. 1650-1655
6 p.
|
artikel
|
Tijdschrift beschrijving